|
인쇄하기
취소
|
HIRA clarifies screening results of cholesterol-lowering agents
Published: 2008-11-21 07:00:00
Updated: 2008-11-21 07:00:00
The Health Insurance Review and Assessment Service (HIRA) reaffirmed its position over the results of lipid-lowering medicines, saying its assessment was made based on their clinical and cost effectiveness profiles.
The HIRA said that as the cholesterol-lowering effect of atorvastatin 10 mg is in the range of simvastatin 20-40mg, the price of atorvastatin 10 mg should be determined in simvas...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.